KRN7000 applied to colorectal cancer research

Role of natural killer T cells in the mouse colitis-associated colon cancer model

Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000

Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer

Tumor-infiltrating effector cells of alpha-galactosylceramide-induced antitumor immunity in metastatic liver tumor

Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(alpha-D-Galactopyranosyl)-2-(N-Hexacosanoylamino)-1,3,4 - octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice

 

Meet Funakoshi Company

Please visit our booth at one of these 2012 meetings:

AACR
Booth# 333
April 1-4, 2012

NIH Spring Festival
Booth# 903
April 25-26, 2012